| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of DCBLD2 mRNA | affects expression | 16483693
|
| D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of DCBLD2 mRNA | increases expression | 17484886
|
| C014347 |
decitabine |
[decitabine affects the methylation of DCBLD2 promoter] which affects the expression of DCBLD2 mRNA | affects expression|affects methylation | 18314483
|
| C014347 |
decitabine |
[decitabine affects the methylation of DCBLD2 promoter] which affects the expression of DCBLD2 protein | affects expression|affects methylation | 18314483
|
| C014347 |
decitabine |
[[decitabine co-treated with trichostatin A] affects the methylation of DCBLD2 promoter] which affects the expression of DCBLD2 mRNA | affects cotreatment|affects expression|affects methylation | 18314483
|
| C014347 |
decitabine |
[[decitabine co-treated with trichostatin A] affects the methylation of DCBLD2 promoter] which affects the expression of DCBLD2 protein | affects cotreatment|affects expression|affects methylation | 18314483
|
| D002117 |
Calcitriol |
Calcitriol results in increased expression of DCBLD2 mRNA | increases expression | 16002434
|
| D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of DCBLD2 gene | increases mutagenesis | 16495775
|
| C006253 |
pirinixic acid |
pirinixic acid results in increased expression of DCBLD2 mRNA | increases expression | 18301758
|
| D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in increased expression of DCBLD2 mRNA | affects cotreatment|increases expression | 19059307
|
| C025462 |
sulindac sulfide |
sulindac sulfide results in increased expression of DCBLD2 mRNA | increases expression | 12734198
|
| D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in increased expression of DCBLD2 mRNA | affects cotreatment|increases expression | 19059307
|
| C012589 |
trichostatin A |
[[decitabine co-treated with trichostatin A] affects the methylation of DCBLD2 promoter] which affects the expression of DCBLD2 mRNA | affects cotreatment|affects expression|affects methylation | 18314483
|
| C012589 |
trichostatin A |
[[decitabine co-treated with trichostatin A] affects the methylation of DCBLD2 promoter] which affects the expression of DCBLD2 protein | affects cotreatment|affects expression|affects methylation | 18314483
|
| C012589 |
trichostatin A |
[trichostatin A affects the methylation of DCBLD2 promoter] which affects the expression of DCBLD2 mRNA | affects expression|affects methylation | 18314483
|
| C012589 |
trichostatin A |
[trichostatin A affects the methylation of DCBLD2 promoter] which affects the expression of DCBLD2 protein | affects expression|affects methylation | 18314483
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.81 | 14745880 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.80 | 18287403 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.30 | 18653653 |
| MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
3.81 | 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.72 | 16434500 |
| MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.79 | 17451421 17308373 |
| MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
4.73 | 15800139 |
| MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
4.73 | 18759972 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.32 | 19483382 |
| MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
5.04 | 14991843 |
| MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.69 | 16580743 |
| MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.45 | 16436596 15144691 16357521 18412241 16651633 |
| MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.03 | 11237771 |
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.03 | 19208741 18320071 |
| MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.03 | 17893378 17242785 16912660 17261762 16837676 15572757 15775269 17952589 17440819 15758505 17049068 17595753 |
| MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.03 | 20065188 19084267 16202921 19221464 18821012 20544844 18351453 17893378 18997820 15565566 20005174 18815881 18425577 20390343 18855134 19155303 19289846 15668708 16818667 19142967 19066611 19189210 18984771 19011961 19487384 11161223 16873071 19115204 19059307 19288272 17242785 19200415 20859285 18629630 21138602 20135344 19410462 17261762 16273361 21152245 19244106 19189212 19103187 17440819 17049068 |
| MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.99 | 15721981 16097048 10355542 16050911 15700767 16192424 15673190 18705752 3786805 16011737 16227642 16124888 |
| MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.72 | 19066611 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
3.08 | 18788625 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.08 | 16924424 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.50 | 12391285 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
5.03 | 11237771 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
5.03 | 19215824 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
10.04 | 17572228 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
10.04 | 17572228 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.56 | 15775269 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
3.84 | 16003739 |
| MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
6.25 | 17160924 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.95 | 19176532 |
| MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.83 | 15800139 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.36 | 17616700 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
| MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.58 | 19031437 |
| MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.31 | 17474826 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.49 | 18249437 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.55 | 17308373 17451421 15920148 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
9.55 | 19279558 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
2.08 | 3786805 19085960 6884620 16227642 7120509 15968718 19336974 21278145 11566570 6623471 7179309 9327722 15998439 10915739 10092053 17522070 15027814 7440962 16177239 3732212 4309450 2869522 |
| MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
6.25 | 18357618 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
7.46 | 12083418 |
| MESH:D004487 |
Edema |
|
Raloxifene |
7.46 | 15860553 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
16.65 | 15138306 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
16.65 | 15845917 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
16.65 | 19031437 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
14.93 | 19294695 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
14.93 | 19294695 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.15 | 19155303 17893378 16202921 20544844 |
| MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
20.28 | 12631006 61145 15959796 16239168 12795759 16045604 17595544 19224547 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
20.28 | 20131406 19236843 |
| MESH:D005234 |
Fatty Liver |
|
Raloxifene |
20.28 | 17473493 |
| MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
20.28 | 19224547 14986274 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.33 | 16709447 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.76 | 14745880 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.42 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
3.67 | 18705752 |
| MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
8.08 | 16436596 |
| MESH:D005909 |
Glioblastoma |
|
trichostatin A |
8.08 | 18801729 |
| MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.55 | 18412241 16357521 16651633 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.60 | 19215824 |
| MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.65 | 11110106 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.63 | 20558911 |
| MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.79 | 19110552 19900420 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.21 | 18467677 16221962 19176532 19772884 |
| MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.77 | 16899240 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.34 | 20558911 |
| MESH:D006973 |
Hypertension |
|
Raloxifene |
2.92 | 15787275 17577099 |
| MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.30 | 15338365 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
3.31 | 17581917 |
| MESH:D007249 |
Inflammation |
|
Tamoxifen |
2.43 | 19457130 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.74 | 16306350 |
| MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
8.22 | 17379185 |
| MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
8.22 | 18625569 |
| MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.68 | 16973256 |
| MESH:D007938 |
Leukemia |
|
decitabine |
3.15 | 19235587 18980019 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.17 | 17236224 18454857 19117987 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.36 | 17679729 18704418 18460780 19387464 19010910 18206229 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
4.36 | 18206229 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.73 | 18055864 |
| MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.27 | 17567588 15342952 |
| MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.89 | 17157831 17334410 11408273 17174718 16943688 16221502 16239168 11903743 21278145 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.55 | 17900296 12546737 18420326 15730626 15123356 12666154 12445421 17823541 17631135 18395914 16097048 14716496 15818738 17714472 16192424 18210741 17525996 16248980 17721639 18376398 12741479 16638106 12632512 17922224 18279442 18412020 15996030 15338365 18205269 17805973 12586293 14748882 18429990 18472332 17640975 12632514 18156304 12898905 17766677 16015684 18395095 18277467 16011737 17557913 18263696 15673190 14716833 15931870 17976157 18251166 17761835 20821823 18187930 14620537 15052691 17944888 18166357 12445418 12667390 15650968 16027843 17698563 16033810 15057751 18418968 18472094 15959796 18705752 15876570 18054572 18481824 15925388 13678700 17869086 17708605 12389079 15362042 14512876 12958196 16136751 10355542 15370692 18339082 11481614 12609069 15893842 17481882 12649538 16116963 14724832 18006644 17565644 18317297 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.55 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.55 | 18564211 |
| MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.12 | 15720792 16246199 17285989 16964402 15830285 |
| MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.38 | 15123358 |
| MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.85 | 14706259 16899240 |
| MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
7.74 | 19294768 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.74 | 20007298 16377806 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.74 | 16684651 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
2.71 | 12014681 15583823 |
| MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
2.80 | 6695378 16019985 17703301 16271038 |
| MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.80 | 18625569 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
8.31 | 19470736 |
| MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
8.31 | 15790496 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
5.26 | 15375218 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.00 | 19428831 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
6.67 | 18041768 10838139 10767621 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.67 | 14580682 16827153 11731420 19196723 19196722 |
| MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.81 | 19453300 |
| MESH:D008545 |
Melanoma |
|
decitabine |
5.39 | 16505122 17785578 |
| MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.39 | 19393235 12393984 |
| MESH:D008545 |
Melanoma |
|
trichostatin A |
5.39 | 16505122 |
| MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.42 | 15990972 |
| MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
6.25 | 17943659 |
| MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.82 | 15863610 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
12.99 | 18172295 |
| MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
12.99 | 16497877 |
| MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
12.99 | 18172295 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.72 | 16239165 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.47 | 19010910 16882708 18608210 19157545 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.20 | 19151258 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.08 | 16411023 |
| MESH:D009232 |
Myxoma |
|
Raloxifene |
5.82 | 16343187 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.60 | 19393235 |
| MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.56 | 19410462 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
5.28 | 17925555 19470736 19116145 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.28 | 17405874 |
| MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.62 | 16707424 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.26 | 19189210 19200415 19196722 |
| MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.65 | 16003739 17160924 16651423 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
| MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
6.25 | 17160924 |
| MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.49 | 19059307 17882678 15775268 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.41 | 17823083 15579764 15758505 17893378 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
5.42 | 19331143 19259094 |
| MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
5.42 | 19331143 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.86 | 19294695 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
5.86 | 19294695 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
13.16 | 17616702 |
| MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
13.16 | 17616702 |
| MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.02 | 15572423 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.12 | 12479363 15754350 18247401 16289102 16644109 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.12 | 16220300 16536755 15731164 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.12 | 15067354 |
| MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.12 | 19789329 18798265 |
| MESH:D011693 |
Purpura |
|
Raloxifene |
5.82 | 15770314 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.46 | 19058328 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.59 | 19155313 |
| MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.56 | 16709447 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.28 | 19457130 |
| MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| 18314483 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
| MESH:D020521 |
Stroke |
|
Raloxifene |
3.96 | 16837676 |
| MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
5.40 | 15790496 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.46 | 17967635 |
| MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.47 | 19048282 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
8.77 | 17616700 19087683 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
8.77 | 17572228 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.77 | 17572228 8653321 16712894 |
| MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
4.85 | 18645019 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.18 | 17785578 |
| MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.47 | 16837676 |
| MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.82 | 16343187 |